{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:29:59Z","timestamp":1793431799204,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.survophthal.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T23:31:31Z","timestamp":1466119891000},"page":"702-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Treatment and management of scleral disorders"],"prefix":"10.1016","volume":"61","author":[{"given":"J.","family":"Daniel Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9512-9012","authenticated-orcid":false,"given":"Ethan K.","family":"Sobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Gritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/09273948.2013.805787","article-title":"Cytomegalovirus-related scleritis","volume":"21","author":"Accorinti","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-8529(18)30090-2","article-title":"Glucocorticoids and osteoporosis","volume":"23","author":"Adler","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2010.24.6.331","article-title":"Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population","volume":"24","author":"Ahn","year":"2010","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10384-008-0652-5","article-title":"Treating refractory scleritis with infliximab","volume":"53","author":"Ahn","year":"2009","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","article-title":"Severity of episcleritis and systemic disease association","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.iio.0000155900.64809.b2","article-title":"The diagnosis and management of anterior scleritis","volume":"45","author":"Albini","year":"2005","journal-title":"Int Ophthalmol Clin"},{"issue":"10","key":"10.1016\/j.survophthal.2016.06.002_bib8","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.ophtha.2005.05.008","article-title":"Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis","volume":"112","author":"Albini","year":"2005","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2016.06.002_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/ICO.0b013e31829ded51","article-title":"Scleral and intraocular amoebic dissemination in acanthamoeba keratitis","volume":"32","author":"Arnalich-Montiel","year":"2013","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/jop.2012.0208","article-title":"Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease","volume":"29","author":"Athanasiadis","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/WNL.48.5.1234","article-title":"Steroid myopathy in cancer patients","volume":"48","author":"Batchelor","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5005\/ijcdas-54-2-135","article-title":"Tubercular nodular\u00a0episcleritis","volume":"54","author":"Bathula","year":"2012","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ajo.2005.01.030","article-title":"Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis","volume":"139","author":"Bauer","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14656566.2013.772982","article-title":"Pharmacotherapy of scleritis: current paradigms and future\u00a0directions","volume":"14","author":"Beardsley","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.survophthal.2016.06.002_bib15","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.24024","article-title":"Severity of baseline magnetic resonance imaging-evident sacroiliitis\u00a0and HLA-B27 status in early inflammatory back\u00a0pain predict radiographically evident ankylosing spondylitis at eight years","volume":"58","author":"Bennett","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Pt 2","key":"10.1016\/j.survophthal.2016.06.002_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/eye.1998.71","article-title":"Successful management of aspergillus scleritis by medical and surgical treatment","volume":"12","author":"Bernauer","year":"1998","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajo.2009.06.025","article-title":"Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity","volume":"148","author":"Bhat","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/09273948.2011.628195","article-title":"Tuberculous scleritis in a patient with rheumatoid arthritis","volume":"20","author":"Biswas","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib19","first-page":"126","article-title":"[Episcleritis and brucellosis. Apropos of a case]","volume":"21","author":"Bourcier","year":"1998","journal-title":"J\u00a0Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199701000-00005","article-title":"Ocular tuberculosis. A prospective study in a general hospital","volume":"76","author":"Bouza","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/rheumatology\/kev196","article-title":"The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis","volume":"54","author":"Calatroni","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib22","first-page":"423","article-title":"Infectious pseudomonas scleritis after strabismus surgery","volume":"17","author":"Chao","year":"2013","journal-title":"J\u00a0AAPOS"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273948.2011.646382","article-title":"High-dose intravenous corticosteroids for ocular inflammatory diseases","volume":"20","author":"Charkoudian","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ophtha.2011.09.030","article-title":"Posterior scleritis in children: clinical features and treatment","volume":"119","author":"Cheung","year":"2012","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/jop.2006.22.168","article-title":"Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease","volume":"22","author":"Choudhary","year":"2006","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/ICO.0b013e31820967bd","article-title":"Management and outcome of microbial anterior scleritis","volume":"30","author":"Cunningham","year":"2011","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib28","first-page":"537","article-title":"A\u00a0group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs","volume":"11","author":"Curtis","year":"2005","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib29","first-page":"107","article-title":"[Lyme borreliosis in Bosnia and Herzegovina\u2013clinical, laboratory and epidemiological research]","volume":"62","author":"Dautovic-Krkic","year":"2008","journal-title":"Med Arh"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00003226-199807000-00005","article-title":"Immunologic and clinical evaluation of postsurgical necrotizing sclerocorneal ulceration","volume":"17","author":"Diaz-Valle","year":"1998","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","article-title":"Infliximab for the treatment of refractory scleritis","volume":"94","author":"Doctor","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.06.002_bib32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.survophthal.2012.11.002","article-title":"The spectrum of postoperative scleral necrosis","volume":"58","author":"Doshi","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICO.0b013e3181ac9fad","article-title":"Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey","volume":"29","author":"Erkanli","year":"2010","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib34","first-page":"238","article-title":"Infectious scleritis after pars plana vitrectomy because of methicillin-resistant staphylococcus aureus resistant to fourth-generation fluoroquinolones","volume":"26","author":"Feiz","year":"2007","journal-title":"Cornea"},{"issue":"8538","key":"10.1016\/j.survophthal.2016.06.002_bib35","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","article-title":"Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone","volume":"1","author":"Felson","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e318033de67","article-title":"Diagnostic and therapeutic challenge of aspergillus flavus scleritis","volume":"26","author":"Fincher","year":"2007","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0161-6420(90)32474-0","article-title":"Episcleritis, conjunctivitis, and keratitis as ocular manifestations of Lyme disease","volume":"97","author":"Flach","year":"1990","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bjo.60.3.227","article-title":"Evaluation of eyes enucleated for scleritis","volume":"60","author":"Fraunfelder","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IAE.0b013e31816576ef","article-title":"Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort","volume":"28","author":"French","year":"2008","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.survophthal.2016.06.002_bib40","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2016.06.002_bib41","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09273948.2011.584010","article-title":"Infectious scleritis after subtenon triamcinolone acetonide injection","volume":"19","author":"Gharaee","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(01)00942-3","article-title":"Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation","volume":"109","author":"Goldstein","year":"2002","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/09273948.2013.840385","article-title":"Clinical features and presentation of posterior scleritis: A report of 31 cases","volume":"22","author":"Gonzalez-Gonzalez","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"10.1016\/j.survophthal.2016.06.002_bib47","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ophtha.2012.01.033","article-title":"Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases","volume":"119","author":"Gonzalez-Gonzalez","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1034\/j.1600-0420.2001.079001076.x","article-title":"Recurrent episcleritis associated with brucellosis","volume":"79","author":"Gungor","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/112067210201200311","article-title":"Ocular complications associated with brucellosis in an endemic area","volume":"12","author":"Gungur","year":"2002","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","article-title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","volume":"8","author":"Harirforoosh","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00417-012-2108-3","article-title":"Ocular hypertension and glaucoma incidence in patients with scleritis","volume":"251","author":"Heinz","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib52","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-012-2035-z","article-title":"Risedronate-associated scleritis: a case report and review of the literature","volume":"31","author":"Hemmati","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0272-6386(96)90046-3","article-title":"Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation","volume":"27","author":"Henrich","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archopht.126.5.651","article-title":"Antineutrophil cytoplasmic antibody-associated active scleritis","volume":"126","author":"Hoang","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib55","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/ICO.0b013e318259c952","article-title":"Epidemiology and visual outcomes in patients with infectious scleritis","volume":"32","author":"Hodson","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2013.05.026","article-title":"Incidence of scleritis and episcleritis: results from the pacific ocular\u00a0inflammation study","volume":"156","author":"Homayounfar","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.06.002_bib57","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/ICO.0b013e3182a407c3","article-title":"Incidence and prevalence of episcleritis and scleritis in northern California","volume":"32","author":"Honik","year":"2013","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.82.1.29","article-title":"Intrascleral dissemination of infectious scleritis following pterygium excision","volume":"82","author":"Hsiao","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00003226-200001000-00008","article-title":"Management of infectious scleritis after pterygium excision","volume":"19","author":"Huang","year":"2000","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib60","first-page":"1093","article-title":"Infectious scleritis after use of immunomodulators","volume":"120","author":"Hwang","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2016.06.002_bib61","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.ophtha.2012.06.035","article-title":"Regional corticosteroids for scleritis","volume":"119","author":"Jabs","year":"2012","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09273940490883671","article-title":"Treatment of ocular inflammation","volume":"12","author":"Jabs","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2007.11.010","article-title":"Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis","volume":"145","author":"Jachens","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.eye.6703099","article-title":"Microbial scleritis-experience from a developing country","volume":"23","author":"Jain","year":"2009","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2009.07.035","article-title":"Evaluation of sub-tenon triamcinolone acetonide injections in the treatment of scleritis","volume":"149","author":"Johnson","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3928\/1542-8877-19960501-15","article-title":"Bilateral fascia lata patch grafts in a patient with progressive scleromalacia perforans","volume":"27","author":"Kachmaryk","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Kacmaz","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib69","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/09273940591004133","article-title":"Masquerade scleritis","volume":"13","author":"Kafkala","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib70","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib71","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archophthalmol.2009.197","article-title":"Atypical infectious nodular scleritis","volume":"127","author":"Kesen","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib72","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bjophthalmol-2012-302130","article-title":"Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease","volume":"97","author":"Khan","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib73","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0002-9394(14)71096-7","article-title":"Nocardia scleritis","volume":"123","author":"Knox","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.06.002_bib74","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/eye.2014.327","article-title":"Use of autologous fascia lata as a natural biomaterial for tectonic support in surgically induced necrotizing scleritis","volume":"29","author":"Kobtan","year":"2015","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib75","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1167\/iovs.02-0589","article-title":"Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in\u00a0vivo","volume":"44","author":"Koizumi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/09273948.2012.689075","article-title":"Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis","volume":"20","author":"Kolomeyer","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib77","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/j.1755-3768.2009.01546.x","article-title":"Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment","volume":"88","author":"Kontkanen","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0161-6420(01)00868-5","article-title":"Posterior scleritis associated with Borrelia burgdorferi (Lyme disease) infection","volume":"109","author":"Krist","year":"2002","journal-title":"Ophthalmology"},{"issue":"6105","key":"10.1016\/j.survophthal.2016.06.002_bib79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.1.6105.88","article-title":"Scleritis and associated disease","volume":"1","author":"Lachmann","year":"1978","journal-title":"Br Med J"},{"issue":"11","key":"10.1016\/j.survophthal.2016.06.002_bib80","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1572-0241.1998.00588.x","article-title":"A\u00a0guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Lanza","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib81","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICL.0b013e3181c6deb0","article-title":"Repair of necrotizing scleritis in ulcerative colitis with processed pericardium and a Prokera amniotic membrane graft","volume":"36","author":"Lazzaro","year":"2010","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib82","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0161-6420(02)01039-4","article-title":"Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression","volume":"109","author":"Lee","year":"2002","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2016.06.002_bib83","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1473-3099(13)70198-1","article-title":"Ocular syphilis characterised by severe scleritis in a patient infected with HIV","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib84","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajo.2012.12.009","article-title":"Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases","volume":"155","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/ICO.0b013e31804e45ba","article-title":"Methicillin-resistant Staphylococcus aureus sclerokeratitis after pterygium excision","volume":"26","author":"Lee","year":"2007","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1185\/03007999209115217","article-title":"Comparison of the effects of etodolac SR and naproxen on gastro-intestinal blood loss","volume":"13","author":"Leese","year":"1992","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.survophthal.2016.06.002_bib87","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1111\/j.1365-2125.2001.00366.x","article-title":"Therapeutic drug monitoring of cytotoxic drugs","volume":"52 Suppl 1","author":"Lennard","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.survophthal.2016.06.002_bib88","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.SMJ.0000152753.80490.9F","article-title":"Bisphosphonate-associated scleritis: a case report and review","volume":"98","author":"Leung","year":"2005","journal-title":"South Med J"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib89","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0161-6420(91)32163-8","article-title":"Diagnosis and therapy of herpes zoster ophthalmicus","volume":"98","author":"Liesegang","year":"1991","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib90","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1442-9071.2006.01225.x","article-title":"Biologic therapies for inflammatory eye disease","volume":"34","author":"Lim","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib91","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","article-title":"Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis","volume":"145","author":"Lin","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2016.06.002_bib92","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3928\/1542-8877-19961201-04","article-title":"Repair of a giant scleral ulcer with preserved sclera and tissue adhesive","volume":"27","author":"Lin","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"issue":"7","key":"10.1016\/j.survophthal.2016.06.002_bib93","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2013.74","article-title":"Choroidal and adnexal extranodal marginal zone B-cell lymphoma: presentation, imaging findings, and therapeutic management in a series of nine cases","volume":"27","author":"Loriaut","year":"2013","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib94","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00055735-200312000-00014","article-title":"Use of immunosuppressive agents in uveitis","volume":"14","author":"Lustig","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"issue":"8473","key":"10.1016\/j.survophthal.2016.06.002_bib95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(86)92291-9","article-title":"Azathioprine and severe bone marrow depression","volume":"1","author":"Maddocks","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0161-6420(00)00585-6","article-title":"Sclerokeratitis: an unusual presentation of squamous cell carcinoma of the conjunctiva","volume":"108","author":"Mahmood","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib97","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/096120339700600307","article-title":"Side-effects of intravenous cyclophosphamide pulse therapy","volume":"6","author":"Martin","year":"1997","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.1987.01060060079037","article-title":"Intravenous pulse methylprednisolone in scleritis","volume":"105","author":"McCluskey","year":"1987","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2016.06.002_bib99","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.60.3.192","article-title":"Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis","volume":"60","author":"McGavin","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib101","first-page":"217","article-title":"Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis","volume":"34","author":"McMullen","year":"1999","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0161-6420(99)00128-1","article-title":"The expanding clinical spectrum of ocular lyme borreliosis","volume":"107","author":"Mikkila","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib103","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1442-9071.2004.00871.x","article-title":"Syphilis presenting as scleritis in an HIV-positive man undergoing immune reconstitution","volume":"32","author":"Moloney","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib104","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.survophthal.2011.10.006","article-title":"Nontuberculous mycobacterial ocular and adnexal infections","volume":"57","author":"Moorthy","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000342842","article-title":"Combined infliximab and rituximab in necrotising scleritis","volume":"3","author":"Morarji","year":"2012","journal-title":"Case Rep Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib106","first-page":"519","article-title":"[A case suspected of early active pulmonary tuberculosis detected by CT with the onset of episcleritis]","volume":"71","author":"Morita","year":"1996","journal-title":"Kekkaku"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib107","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1358\/dot.2011.47.5.1590791","article-title":"Difluprednate for inflammatory eye disorders","volume":"47","author":"Mulki","year":"2011","journal-title":"Drugs Today (Barc)"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bjo.76.1.17","article-title":"Surgically induced necrotising sclerokeratitis (SINS)\u2013precipitating factors and response to treatment","volume":"76","author":"O'Donoghue","year":"1992","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib109","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib110","first-page":"1893","article-title":"Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning","volume":"36","author":"Olsen","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib111","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ajo.2010.02.011","article-title":"Subconjunctival triamcinolone acetonide injection in the treatment of acute noninfectious nonnecrotizing anterior scleritis","volume":"149","author":"Onal","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"6-7","key":"10.1016\/j.survophthal.2016.06.002_bib112","first-page":"410","article-title":"[Prognostic factors of choroidal melanoma: an anatomo-clinical retrospective and statistical study of 76 enucleated cases]","volume":"15","author":"Panigel","year":"1992","journal-title":"J\u00a0Fr Ophtalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib113","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib114","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.ico.0000164784.18290.45","article-title":"Atypical pneumococcal scleritis after pterygium excision: case report and literature review","volume":"25","author":"Paula","year":"2006","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00055735-200112000-00013","article-title":"Systemic disorders associated with episcleritis and scleritis","volume":"12","author":"Pavesio","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"issue":"3-4","key":"10.1016\/j.survophthal.2016.06.002_bib116","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1076\/soph.17.3.124.14786","article-title":"Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease","volume":"17","author":"Perez","year":"2002","journal-title":"Semin Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib117","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","article-title":"Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs","volume":"114","author":"Piper","year":"1991","journal-title":"Ann Intern Med"},{"issue":"8025","key":"10.1016\/j.survophthal.2016.06.002_bib118","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(77)91336-8","article-title":"Cyclophosphamide and malignancy","volume":"1","author":"Puri","year":"1977","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib119","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajo.2009.07.021","article-title":"Scleritis and systemic disease association in a community-based referral practice","volume":"148","author":"Raiji","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2016.06.002_bib120","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/S0161-6420(99)90520-1","article-title":"Episcleritis in childhood","volume":"106","author":"Read","year":"1999","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1442-9071.1997.tb01270.x","article-title":"Choroidal melanoma: a review of the experience of the Sydney Eye Hospital Professorial Unit 1979-1995","volume":"25","author":"Reader","year":"1997","journal-title":"Aust N Z J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10067-009-1368-8","article-title":"Successful treatment of severe nodular scleritis with adalimumab","volume":"29","author":"Restrepo","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib123","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajo.2007.11.024","article-title":"Infectious scleritis after retinal surgery","volume":"145","author":"Rich","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib124","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3928\/1542-8877-19990601-14","article-title":"Repair of scleral perforation with preserved scleral and amniotic membrane in Marfan's syndrome","volume":"30","author":"Rodriguez-Ares","year":"1999","journal-title":"Ophthalmic Surg Lasers"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archophthalmol.2011.1527","article-title":"Scleritis associated with toxoplasmic retinochoroiditis","volume":"130","author":"Rudich","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3341\/kjo.2013.27.4.291","article-title":"Contact lens-associated nocardial necrotizing scleritis","volume":"27","author":"Rush","year":"2013","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.06.002_bib127","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0161-6420(91)32062-1","article-title":"Necrotizing scleritis after ocular surgery. A clinicopathologic study","volume":"98","author":"Sainz de la Maza","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0161-6420(97)30361-3","article-title":"Scleritis-associated uveitis","volume":"104","author":"Sainz de la Maza","year":"1997","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","article-title":"Scleritis associated with systemic vasculitic diseases","volume":"102","author":"Sainz de la Maza","year":"1995","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01203568","article-title":"Infectious scleritis: report of four cases","volume":"83","author":"Sainz de la Maza","year":"1993","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib131","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","article-title":"Severity of scleritis and episcleritis","volume":"101","author":"Sainz de la Maza","year":"1994","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib132","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0161-6420(93)31473-9","article-title":"An analysis of therapeutic decision for scleritis","volume":"100","author":"Sainz de la Maza","year":"1993","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib133","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib134","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","article-title":"Scleritis therapy","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9394(99)80197-4","article-title":"The use of processed pericardial tissue in anterior ocular segment reconstruction","volume":"125","author":"Schein","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib136","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9394(89)90449-2","article-title":"Sclerokeratitis caused by Mycobacterium marinum","volume":"108","author":"Schonherr","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib137","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","article-title":"Infliximab for the treatment of active scleritis","volume":"44","author":"Sen","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.06.002_bib138","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib139","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09273940802140804","article-title":"Nocardia asteroides necrotizing scleritis associated with subtenon triamcinolone acetonide injection","volume":"16","author":"Seth","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/eop.09.70","article-title":"Drug delivery to the posterior segment of the eye for pharmacologic therapy","volume":"5","author":"Shah","year":"2010","journal-title":"Expert Rev Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib141","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1167\/iovs.13-12660","article-title":"Difluprednate 0.05% versus prednisolone acetate 1% for endogenous\u00a0anterior uveitis: a phase III, multicenter, randomized study","volume":"55","author":"Sheppard","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib142","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","article-title":"Therapy insight: scleritis and its relationship to systemic autoimmune disease","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Clin Pr Rheumatol"},{"issue":"7","key":"10.1016\/j.survophthal.2016.06.002_bib143","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archopht.125.7.895","article-title":"Infliximab therapy for the treatment of refractory ocular inflammatory disease","volume":"125","author":"Sobrin","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2016.06.002_bib144","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ophtha.2011.02.043","article-title":"Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis","volume":"118","author":"Sohn","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00003226-200003000-00002","article-title":"Lamellar corneal patch grafts in the management of corneal melting","volume":"19","author":"Soong","year":"2000","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib146","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.survophthal.2016.06.002_bib147","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2147\/OPTH.S12441","article-title":"Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%","volume":"4","author":"Stringer","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib148","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.ico.0000214228.44109.0f","article-title":"Immunologic and clinical manifestations of infectious scleritis after pterygium excision","volume":"25","author":"Su","year":"2006","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.survophthal.2016.06.002_bib149","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","article-title":"Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial","volume":"121","author":"Suhler","year":"2014","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2016.06.002_bib150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A\u00a0prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib151","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09273940802056281","article-title":"Nodular scleritis following alendronate therapy","volume":"16","author":"Tabbara","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.survophthal.2016.06.002_bib152","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0161-6420(97)30142-0","article-title":"Infectious posterior scleritis caused by Pseudallescheria boydii. Clinicopathologic findings","volume":"104","author":"Taravella","year":"1997","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib153","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0974-9233.102765","article-title":"Amniotic membrane transplantation in surgically induced necrotizing scleritis with peripheral ulcerative keratitis","volume":"19","author":"Thatte","year":"2012","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib154","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12348-012-0062-1","article-title":"Early surgical debridement in the management of infectious scleritis after pterygium excision","volume":"2","author":"Tittler","year":"2012","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jnci\/78.3.459","article-title":"Leukemia after therapy with alkylating agents for childhood cancer","volume":"78","author":"Tucker","year":"1987","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.survophthal.2016.06.002_bib156","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","article-title":"Progression of scleral disease","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"issue":"6890","key":"10.1016\/j.survophthal.2016.06.002_bib157","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/bmj.306.6890.1477-d","article-title":"Sleep disorders. Steroids cause sleep disturbance","volume":"306","author":"Turner","year":"1993","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib158","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.06.002_bib159","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","article-title":"Scleral structure, organisation and disease. A review","volume":"78","author":"Watson","year":"2004","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2016.06.002_bib160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","article-title":"Visual outcome, treatment results, and prognostic factors in patients with scleritis","volume":"120","author":"Wieringa","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib161","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9394(87)90170-X","article-title":"Syphilitic episcleritis and scleritis","volume":"104","author":"Wilhelmus","year":"1987","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2016.06.002_bib162","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.eye.6701632","article-title":"A\u00a0randomised, double-blind trial of topical ketorolac vs artificial tears for\u00a0the treatment of episcleritis","volume":"19","author":"Williams","year":"2005","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib163","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archopht.1983.01040010044004","article-title":"Complications of herpes zoster ophthalmicus","volume":"101","author":"Womack","year":"1983","journal-title":"Arch Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.survophthal.2016.06.002_bib164","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","article-title":"Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate","volume":"301","author":"Yamaguchi","year":"2005","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4038\/cmj.v55i1.1703","article-title":"A\u00a0case series of symptomatic ocular tuberculosis and the response to anti-tubercular therapy","volume":"55","author":"Yasaratne","year":"2010","journal-title":"Ceylon Med J"},{"issue":"6","key":"10.1016\/j.survophthal.2016.06.002_bib166","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0731-7085(02)00515-0","article-title":"Analysis of an anti-inflammatory steroidal drug, difluprednate, in aqueous\u00a0humor by combination of semi-micro HPLC and column switching method","volume":"30","author":"Yasueda","year":"2003","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.survophthal.2016.06.002_bib167","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1869-5760-3-48","article-title":"Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?","volume":"3","author":"Yates","year":"2013","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"issue":"5","key":"10.1016\/j.survophthal.2016.06.002_bib168","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(85)90057-9","article-title":"Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus","volume":"79","author":"Zizic","year":"1985","journal-title":"Am J Med"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715300825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715300825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:41:26Z","timestamp":1758541286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625715300825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":168,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0039625715300825"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.06.002","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and management of scleral disorders","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}